EFFECTS OF MAJOR HISTOCOMPATIBILITY COMPLEX ON AUTOIMMUNE-DISEASE OF H-2-CONGENIC NEW-ZEALAND MICE

被引:51
作者
HIROSE, S [1 ]
KINOSHITA, K [1 ]
NOZAWA, S [1 ]
NISHIMURA, H [1 ]
SHIRAI, T [1 ]
机构
[1] JUNTENDO UNIV,SCH MED,DEPT PATHOL,2-1-1 HONGO,BUNKYO KU,TOKYO 113,JAPAN
关键词
Class II molecule; H-2; Heterozygosity; T cell receptor;
D O I
10.1093/intimm/2.11.1091
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Autoimmune-prone NZB mice mainly produce IgM-class anti-DNA antibodies and mild SLE develops later in life. The F1 hybrid of NZB and non-autoimmune NZW mice (NZB/W F1 mice) develop a more fulminant SLE, associated with decreases In IgM class, and, In turn, increases in IgG class antl-DNA antibodies. To elucidate the role of the H-2 complex In this mode of anti-DNA antibody production, we established and studied H-2-congenic New Zealand mice, i.e. NZB, NZW, and NZB/W F1 mice with either the homozygous H-2x/H-2x or H-2d/H-2d haplotype or the heterozygous H-2d/H-2x haplotype. The data showed that: (I) although the nonH-2-linked NZB gene(s) seems to determine the IgM antl-DNA antibody production In NZB mice, the effect of this gene is fully expressed only in the case of the H-2d/H-2d homozygous state, (ii) The production of IgG antl-DNA antibodies observed in NZB/W F1 hybrid mice Is restricted to the H-2d/H-2x heterozygosity. (III) Because both NZB and NZW mice with the H-2d/H-2x haplotype produce a lower titer of IgG anti-DNA antibodies than do the NZB/W F1, mice, other complementary non-H-2-linked genetic elements from both NZB and NZW parents are required. The development of lupus nephritis correlated well with that of anti-DNA antibodies. Thus, H-2d/H-2xheterozygosity is a necessary but not sufficient condition for the development of autoimmunity in NZB/W F1 mice. We discuss the possibilities that these effects of the H-2 complex are linked to class II molecules and are fully expressed in association with other non-H-2-linked genetic elements. © 1990 Oxford University Press.
引用
收藏
页码:1091 / 1095
页数:5
相关论文
共 28 条
  • [1] GENETIC-ANALYSIS OF THE IMPERFECT ASSOCIATION OF H-2 HAPLOTYPE WITH LUPUS-LIKE AUTOIMMUNE-DISEASE
    BABCOCK, SK
    APPEL, VB
    SCHIFF, M
    PALMER, E
    KOTZIN, BL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (19) : 7552 - 7555
  • [2] Bielschowsky Marianne, 1959, P U OTAGO MED SCH, V37, P9
  • [3] CHIANG BL, 1990, J IMMUNOL, V145, P94
  • [4] GENETIC-CONTROL OF SPECIFIC IMMUNE SUPPRESSION .2. H-2-LINKED DOMINANT GENETIC-CONTROL OF IMMUNE SUPPRESSION BY RANDOM COPOLYMER L-GLUTAMIC ACID 50-L-TYROSINE50 (GT)
    DEBRE, P
    KAPP, JA
    DORF, ME
    BENACERRAF, B
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1975, 142 (06) : 1447 - 1454
  • [5] ENZYME-IMMUNOASSAY FOR ANTIBODIES TO NATIVE DNA - SPECIFICITY AND QUALITY OF ANTIBODIES
    EATON, RB
    SCHNNEIDER, G
    SCHUR, PH
    [J]. ARTHRITIS AND RHEUMATISM, 1983, 26 (01): : 52 - 62
  • [6] ANTI-RO(SSA) AUTOANTIBODIES ARE ASSOCIATED WITH T-CELL RECEPTOR BETA-GENES IN SYSTEMIC LUPUS-ERYTHEMATOSUS PATIENTS
    FRANK, MB
    MCARTHUR, R
    HARLEY, JB
    FUJISAKU, A
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (01) : 33 - 39
  • [7] T-CELL-RECEPTOR BETA-CHAIN AND I-A-BETA-CHAIN GENES OF NORMAL SWR MICE ARE LINKED WITH THE DEVELOPMENT OF LUPUS NEPHRITIS IN NZB X SWR CROSSES
    GHATAK, S
    SAINIS, K
    OWEN, FL
    DATTA, SK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (19) : 6850 - 6853
  • [8] CHRONIC THERAPY WITH RECOMBINANT TUMOR NECROSIS FACTOR-ALPHA IN AUTOIMMUNE NZB/NZW F1-MICE
    GORDON, C
    RANGES, GE
    GREENSPAN, JS
    WOFSY, D
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1989, 52 (03): : 421 - 434
  • [9] 2 RO (SS-A) AUTOANTIBODY RESPONSES IN SYSTEMIC LUPUS-ERYTHEMATOSUS - CORRELATION OF HLA-DR/DQ SPECIFICITIES WITH QUANTITATIVE EXPRESSION OF RO (SS-A) AUTOANTIBODY
    HAMILTON, RG
    HARLEY, JB
    BIAS, WB
    ROEBBER, M
    REICHLIN, M
    HOCHBERG, MC
    ARNETT, FC
    [J]. ARTHRITIS AND RHEUMATISM, 1988, 31 (04): : 496 - 505
  • [10] HIROSE S, 1986, EUR J IMMUNOL, V16, P1631, DOI 10.1002/eji.1830161226